These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24823512)

  • 1. IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.
    Mehtap O; Atesoglu EB; Tarkun P; Hacihanefioglu A; Dolasik I; Musul MM
    J Postgrad Med; 2014; 60(2):141-4. PubMed ID: 24823512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
    Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
    Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
    Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
    Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.
    Umare V; Pradhan V; Nadkar M; Rajadhyaksha A; Patwardhan M; Ghosh KK; Nadkarni AH
    Mediators Inflamm; 2014; 2014():385297. PubMed ID: 25548434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of proinflammatory cytokine levels in sera from patients with Kaschin-Beck disease].
    Zhu CS; Feng QH; Yu YX; Wang DL; Chen M; Wang XY; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):84-5. PubMed ID: 16388753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of hepcidin in the anemia of multiple myeloma.
    Sharma S; Nemeth E; Chen YH; Goodnough J; Huston A; Roodman GD; Ganz T; Lichtenstein A
    Clin Cancer Res; 2008 Jun; 14(11):3262-7. PubMed ID: 18519751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease.
    Saxena S; Pant AB; Khanna VK; Agarwal AK; Singh K; Kumar D; Singh VK
    Ocul Immunol Inflamm; 2009; 17(3):201-6. PubMed ID: 19585364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
    Castoldi G; Galimberti S; Riva C; Papagna R; Querci F; Casati M; Zerbini G; Caccianiga G; Ferrarese C; Baldoni M; Valsecchi MG; Stella A
    Clin Sci (Lond); 2007 Jul; 113(2):103-8. PubMed ID: 17362204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of interleukin-22 in multiple myeloma.
    Tsirakis G; Pappa CA; Kolovou A; Kokonozaki M; Neonakis I; Alexandrakis MG
    Hematology; 2015 Apr; 20(3):143-7. PubMed ID: 25055724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
    Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Values of Detecting the Levels of β2-MG, TNF-α, CRP, IL-6 in the Patients with Multiple Myeloma].
    Duan LJ; Li C; Yang RY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1362-5. PubMed ID: 26524038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cytokines and cancer in involuntary weight loss.
    Baicus C; Caraiola S; Rimbas M; Patrascu R; Baicus A;
    J Investig Med; 2012 Jun; 60(5):827-9. PubMed ID: 22481167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated circulating IL-1beta and TNF-alpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome.
    Vitoratos N; Papadias C; Economou E; Makrakis E; Panoulis C; Creatsas G
    Mediators Inflamm; 2006; 2006(4):30485. PubMed ID: 17047289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines in Alzheimer's disease and vascular dementia.
    Angelopoulos P; Agouridaki H; Vaiopoulos H; Siskou E; Doutsou K; Costa V; Baloyiannis SI
    Int J Neurosci; 2008 Dec; 118(12):1659-72. PubMed ID: 18937113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.